- Citations, last 5 years
- 68
- Works, last 5 years
- 7
- h-index
- 20
- Scientists listed
- 3
- Grants since 2016
- 3
Grants received
2017 · grant · Prevent & Delay
Pre-clinical development of a novel insulin-fusion protein to eliminate insulin-specific autoimmunity and prevent type 1 diabetes
Akston Biosciences (United States) · funded by Leona M. and Harry B. Helmsley Charitable Trust
2015–2021 · research · R44
IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes
Todd C Zion · Akston Biosciences (United States) · funded by National Institutes of Health
2015–2022 · research · R44
IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes
Todd C Zion · Akston Biosciences (United States) · funded by National Institutes of Health